Adagio Medical Inc.
ADGM | NASDAQ
$0.49
-$0.01 (-2.58%)
Sep 22, 2026, 11:19 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 |
|---|---|---|---|---|---|
Net Income | -25.08M | -75.04M | -2.13M | -23.67M | -19.94M |
Depreciation & Amortization | 970K | 1.39M | n/a | 495K | 336K |
Stock-Based Compensation | 1.48M | n/a | n/a | 365K | 339K |
Other Working Capital | 3.45M | 9.69M | 4.03M | -174K | 733K |
Other Non-Cash Items | 960K | 40.33M | -2.62M | 71K | -623K |
Deferred Income Tax | n/a | -1.92M | n/a | n/a | n/a |
Change in Working Capital | 2.66M | 5.79M | 4.03M | 330K | 579K |
Operating Cash Flow | -19.01M | -29.46M | -725.86K | -22.41M | -19.31M |
Capital Expenditures | -374K | -1.65M | -2 | -492K | -1.27M |
Cash Acquisitions | n/a | n/a | n/a | 2K | n/a |
Purchase of Investments | n/a | n/a | -1.4M | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | 115.07M | n/a | -14K |
Investing Cash Flow | -374K | -1.65M | 113.67M | -500K | -1.27M |
Debt Repayment | n/a | 15.63M | 2.06M | 9.5M | n/a |
Common Stock Repurchased | n/a | n/a | -115.07M | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | 130K |
Financial Cash Flow | 16.13M | 15.63M | -113.02M | 9.53M | 130K |
Net Cash Flow | -3.48M | 20.57M | -5.53M | 5.05M | -20.38M |
Free Cash Flow | -19.39M | -31.11M | -725.86K | -22.9M | -20.58M |
Adj. Free Cash Flow | -20.87M | -31.11M | -725.86K | -23.27M | -20.92M |
Maintenance CapEx | -374K | -1.65M | n/a | -492K | n/a |
Growth CapEx | n/a | n/a | -2 | n/a | -1.27M |
Owner Earnings | -19.39M | -31.11M | -725.86K | -22.9M | -19.31M |
Add to Watchlist
Select watchlists to add or remove ADGM